Histamine H3-receptors: A new frontier in myocardial ischemia

Journal of Pharmacology and Experimental Therapeutics

Volumn 292, Issue 3, 2000, Pages 825-830

  Levi, Roberto ^a   Smith, Neil C E ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE TRIPHOSPHATE; CLOBENPROPIT; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR AGONIST; IMETIT; NORADRENALIN;

ADRENERGIC NERVE; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL HYPOXIA; CONTROLLED STUDY; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HUMAN; HUMAN TISSUE; NONHUMAN; NORADRENALIN RELEASE; PH; PRIORITY JOURNAL; REVIEW; SYMPATHETIC NERVE;

ANIMALS; GUINEA PIGS; HISTAMINE AGONISTS; HUMANS; MYOCARDIAL ISCHEMIA; NOREPINEPHRINE; RECEPTORS, HISTAMINE H3; SIGNAL TRANSDUCTION;

EID: 0034104595     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. 3) of histamine receptor. Nature 302:832-837.
2. 1-adenosine receptor agonist in guinea pig isolated heart. J Pharmacol Exp Ther 271:1371-1382.
3. Biedler JL, Helson L and Spengler BA (1973) Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33:2643-2652.
4. 3 receptor negatively coupled to phosphoinositide turnover in the human gastric cell line HGT1. J Biol Chem 267:25315-25320.
5. 2+ channels. J Pharmacol Exp Ther 269:221-229.
6. Haass M, Cheng B, Richardt G, Lang RE and Schömig A (1989) Characterization and presynaptic modulation of stimulation-evoked exocytotic co-release of noradrenaline and neuropeptide Y in guinea pig heart. Naunyn Schmiedebergs Arch Pharmacol 339:71-78.
7. Hatta E, Maruyama R, Marshall SJ, Imamura M and Levi R (1999) Bradykinin promotes ischemic norepinephrine release in guinea pig and human hearts. J Pharmacol Exp Ther 288:919-927.
8. 3 receptors inhibits carrier-mediated norepinephrine release in a human model of protracted myocardial ischemia. J Pharmacol Exp Ther 283:494-500.
9. 3-receptors. Br J Pharmacol 107:347-351.
10. Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, Schunack W, Levi R and Haas HL (1997) International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 49:253-278.
11. 2-adrenoceptors. Circ Res 78:475-481.
12. 3-receptors in myocardial ischemia: Their role as regulators of exocytotic norepinephrine release. J Pharmacol Exp Ther 271:1259-1266.
13. 3-receptors in the human heart. Circ Res 77:206-210.
14. 3-receptor-mediated inhibition of calcitonin gene-related peptide release from cardiac C fibers - A regulatory negative-feedback loop. Circ Res 78:863-869.
15. 3) of histamine receptors on perivascular nerve terminals. Nature 327:158-160.
16. Kübler W and Strasser RH (1994) Signal transduction in myocardial ischaemia (Editorial). Eur Heart J 15:437-445.
17. Kurz T, Richardt G, Hagl S, Seyfarth M and Schömig A (1995) Two different mechanisms of noradrenaline release during normoxia and simulated ischemia in human cardiac tissue. J Mol Cell Cardiol 27:1161-1172.
18. 1-adrenergic system and arrhythmias in ischaemic heart disease. Eur Heart J 12 (Suppl F):88-98.
19. Langer SZ (1977) Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmacol 60:481-497.
20. Levi R, Rubin LE and Gross SS (1991) Histamine in cardiovascular function and dysfunction: Recent developments, in Handbook Experimental Pharmacology, Histamine and Histamine Antagonists (Uvnas B. ed) vol 97, pp 347-383, Springer-Verlag, Berlin-Heidelberg.
21. 3 receptor. Mol Pharmacol 56:1101-1107.
22. 3-receptors inhibit sympathetic neurotransmission in guinea pig myocardium. Eur J Pharmacol 204:311-314.
23. 3 receptors: General characterization and their function in the cardiovascular system. J Physiol Pharmacol 49:191-211.
24. 3 receptors in the pithed rat. Naunyn Schmiedebergs Arch Pharmacol 347:55-60.
25. Maruyama R, Hatta E and Levi R (1999) Norepinephrine release and ventricular fibrillation in myocardial ischemia/reperfusion: Roles of angiotensin and bradykinin. J Cardiovasc Pharmacol 34:913-915.
26. 3-receptor stimulation is unable to modulate noradrenaline release by the isolated rat heart during ischaemia-reperfusion. Fundam Clin Pharmacol 13:455-460.
27. 3-histaminergic inhibition of cardiac sympathetic stimulation by R-α-methyl-histamine and its prodrug BP 2.94 in the dog. Br J Pharmacol 126:264-268.
28. 3 receptor activation. Eur J Pharmacol 259:211-214.
29. + in neuronal uptake: Kinetic evidence for co-transport. Naunyn Schmiedebergs Arch Pharmacol 309:99-107.
30. Schömig A (1990) Catecholamines in myocardial ischemia. Systemic and cardiac release. Circulation 82 (Suppl 3):II 13-22.
31. Schömig A, Haass M and Richardt G (1991) Catecholamine release and arrhythmias in acute myocardial ischaemia. Eur Heart J 12 (Suppl F):38-47.
32. 3-receptors in a canine model of pacing-induced heart failure: A cause of increased norepinephrine release (Abstract)? Circulation 94:I-406.
33. Seyedi N, Maruyama R and Levi R (1999) Bradykinin activates a cross-signaling pathway between sensory and adrenergic nerve endings in the heart: A novel mechanism of ischemic norepinephrine release? J Pharmacol Exp Ther 290:656-663.
34. 2-receptor activation augments norepinephrine exocytosis from cardiac sympathetic nerve endings. Mediation by autocrine/paracrine mechanisms. Circ Res 81:774-784.
35. Takeshita Y, Watanabe T, Sakata T, Munakata M, Ishibashi H and Akaike N (1998) Histamine modulates high-voltage-activated calcium channels in neurons dissociated from the rat tuberomammillary nucleus. Neuroscience 87:797-805.
36. Vaughan PF, Peers C and Walker JH (1995) The use of the human neuroblastoma SH-SY5Y to study the effect of second messengers on noradrenaline release. Gen Pharmacol 26:1191-1201.